Royalty Report: Drugs, Biotechnology, Diagnostic – Collection: 26453


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4

Primary Industries

  • Drugs
  • Biotechnology
  • Diagnostic
  • Disease
  • Diagnostic Substances
  • Therapeutic
  • Drug Discovery
  • Vaccine

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26453

License Grant
This Agreement, effective the University hereby grants to Company a worldwide, exclusive license with right to sublicense, to use Patent Rights and Know-How, to make, use, sell and have made Licensed Products, Licensed Combination Products, Licensed Processes, and Licensed Services in the Field of Use.  Sublicensees shall be subject to the terms and conditions of this Agreement.
License Property
University is the owner of their entire right, title and interest in the invention entitled 'Chlamydia Vaccine' which is the subject of three provisional United States Patent Applications, Serial Numbers 60/082,438; Licensed Combination Products shall mean any product that is comprised in part of a Licensed Product and in part of one or more other biologically active diagnostic, preventive or therapeutic agents which are not themselves Licensed Products (the Other Agents).

Chlamydia is an infection, a sexually transmitted disease.

Other Agents excludes diluents and vehicles of Licensed Products; vaccines for the prevention of disease caused by one or more of the following Chlamydia trachomatis, Chlamydia pneumonia, and Chlamydia psittaci; family of proteins involved in the formation of inclusion bodies which are crucial in the Chlamydia life cycle IncA, IncB, and IncC as well as TroA – April 13, 1998.

Field of Use
Field of Use shall mean all fields of use.

IPSCIO Record ID: 1150

License Grant
The Licensor granted an exclusive, worldwide license to the relevant Diagnostic Technology.

Diagnostic Technology  means any information, inventions, and discoveries made, conceived, derived, or otherwise reduced to practice by Licensor related to the Field.

License Property
U.S. Patent No. 5,516,638 Immunoassays for the Detection of Antibodies to Chlamydia Trachomatis in the Urine.
Field of Use
Field of Use means any urine-based medical diagnostic test.

IPSCIO Record ID: 2386

License Grant
The Licensor, an individual, and the Licensee desire to hereby amend and restate the Original Agreement in its entirety to clarify certain rights and obligations of the parties from and after March 1, 1997.
License Property
Licensor owns U.S. Patent No. 5,516,638 Immunoassays for the Detection of Antibodies to Chlamydia Trachomatis in the Urine.  Issued May 14, 1996.
Field of Use
The Field means any urine-based medical diagnostic test.

IPSCIO Record ID: 308732

License Grant
The College grants to Licensee an exclusive, worldwide license, under the Patent Rights solely (a) to identify, discover, develop, make, have made, use, market, offer for sale, sell, have sold and import Type I and Type II Licensed Products and (b) to perform Licensed Services.

The College grants to Licensee a non-exclusive, worldwide, license under its rights in and to the College Technology Transfer Materials solely for use in identifying, discovering, developing, making, having made, using, marketing, offering for sale, selling, having sold and importing any Type I Licensed Product or Type II Licensed Product.

License Property
The College has patent rights covering certain chlamydia antigens.

Type I Licensed Product shall mean any product, the manufacture, use, sale, marketing or importation of which falls within the scope of a Valid Claim in the country in which it is manufactured, used, sold, marketed or imported.  Type II Licensed Product' shall mean any product that is not a Type I Licensed Product, but is identified or discovered through the use of a Licensed Method.

Licensed Services shall mean any service provided for or on behalf of a third party on a fee-for-service basis that entails the practice of a Licensed Method.

Materials transferred include
– Chlamydia libraries (donor library and expression library with and without cLLO)
– pDEST-SL8 expression vector
– Plasmids and E. Coli Strains
– T cell Lines
– Other Cell Lines, and,
– Protocols as follows
1. Gateway cloning
2. CE6 phage prep
3. Library induction
4. Library screening
5. Chlamydia growth and prep
6. T cell expansion (multiple protocols)
7. APC preps
8. Chlamydia infection ( cell line and mouse)
9. B3Z assay for library validation
10. ICS assay for antigen presentation

Field of Use
The field of use is for development of the first such chlamydia vaccine.  The patent families cover chlamydia vaccine and immunogenic compositions and methods for inhibiting or treating chlamydia infections.

Chlamydia, or more specifically a chlamydia infection, is a sexually transmitted infection caused by the bacterium Chlamydia trachomatis.

Licensee is a clinical stage biotechnology company that discovers and develops novel vaccines to address infectious diseases for which no vaccine or vaccines with limited effectiveness exist today.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.